Your browser doesn't support javascript.
loading
Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report.
Harris, Jacqueline K; Hassel, Stefanie; Davis, Andrew D; Zamyadi, Mojdeh; Arnott, Stephen R; Milev, Roumen; Lam, Raymond W; Frey, Benicio N; Hall, Geoffrey B; Müller, Daniel J; Rotzinger, Susan; Kennedy, Sidney H; Strother, Stephen C; MacQueen, Glenda M; Greiner, Russell.
Afiliação
  • Harris JK; Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada; Alberta Machine Intelligence Institute, Edmonton, Alberta, Canada. Electronic address: jkh@ualberta.ca.
  • Hassel S; Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute, Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, Alberta, Canada.
  • Davis AD; Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.
  • Zamyadi M; Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Arnott SR; Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.
  • Milev R; Departments of Psychiatry and Psychology, Queen's University, and Providence Care, Kingston, Ontario, Canada.
  • Lam RW; Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.
  • Frey BN; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada; Mood Disorders Program and Women's Health Concerns Clinic, St. Joseph's Healthcare, Hamilton, Ontario, Canada.
  • Hall GB; Department of Psychology, Neuroscience & Behaviour, McMaster University, and St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
  • Müller DJ; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada; Institute of Me
  • Rotzinger S; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Centre for Depression and Suicide Studies, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Kennedy SH; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Centre for Depression and Suicide Studies, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Strother SC; Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • MacQueen GM; Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute, Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, Alberta, Canada.
  • Greiner R; Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada; Alberta Machine Intelligence Institute, Edmonton, Alberta, Canada; Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada.
Neuroimage Clin ; 35: 103120, 2022.
Article em En | MEDLINE | ID: mdl-35908308

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Transtorno Depressivo Maior Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Neuroimage Clin Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Transtorno Depressivo Maior Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Neuroimage Clin Ano de publicação: 2022 Tipo de documento: Article